PRMT1 and hepatocellular carcinoma: To further verify the association between PRMT1 expression and clinicopathological outcomes in HCC patients, we categorized PRMT1 expression in HCC and PRMT1 expression in Tex of HCC into two groups, as previously outlined (Figure 8D,E), with no statistical difference in clinical characteristics (Supplement Tables S1 and S2).